Redsense Medical AB (publ)
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flo… Read more
Redsense Medical AB (publ) (RDSNF) - Total Assets
Latest total assets as of June 2024: $34.38 Million USD
Based on the latest financial reports, Redsense Medical AB (publ) (RDSNF) holds total assets worth $34.38 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Redsense Medical AB (publ) - Total Assets Trend (2019–2023)
This chart illustrates how Redsense Medical AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Redsense Medical AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2023)
Redsense Medical AB (publ)'s total assets of $34.38 Million consist of 50.0% current assets and 50.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.3% |
| Accounts Receivable | $2.97 Million | 11.2% |
| Inventory | $1.27 Million | 4.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.90 Million | 48.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2023)
This chart illustrates how Redsense Medical AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Redsense Medical AB (publ)'s current assets represent 50.0% of total assets in 2023, a decrease from 79.9% in 2019.
- Cash Position: Cash and equivalents constituted 26.3% of total assets in 2023, down from 45.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 18.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 48.7% of total assets.
Redsense Medical AB (publ) Competitors by Total Assets
Key competitors of Redsense Medical AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Redsense Medical AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Redsense Medical AB (publ) generates 0.94x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Redsense Medical AB (publ) is currently not profitable relative to its asset base.
Redsense Medical AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.86 | 3.74 | 5.48 |
| Quick Ratio | 4.00 | 3.42 | 4.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $16.32 Million | $ 11.45 Million | $ 15.97 Million |
Redsense Medical AB (publ) - Advanced Valuation Insights
This section examines the relationship between Redsense Medical AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.78 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | -13.8% |
| Total Assets | $26.50 Million |
| Market Capitalization | $5.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Redsense Medical AB (publ)'s assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Redsense Medical AB (publ)'s assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Redsense Medical AB (publ) (2019–2023)
The table below shows the annual total assets of Redsense Medical AB (publ) from 2019 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $26.50 Million | -13.75% |
| 2022-12-31 | $30.73 Million | -28.95% |
| 2021-12-31 | $43.25 Million | -45.05% |
| 2020-12-31 | $78.70 Million | +314.43% |
| 2019-12-31 | $18.99 Million | -- |